Advised Lundbeck on patent infringement, extension and validity litigation against four generic pharmaceutical companies regarding an anti-depressant sold as Lexapro, in a 14-year dispute in the Patent Office and Federal Court, with success on liability and damages.


This publication is introductory in nature. Its content is current at the date of publication. It does not constitute legal advice and should not be relied upon as such. You should always obtain legal advice based on your specific circumstances before taking any action relating to matters covered by this publication. Some information may have been obtained from external sources, and we cannot guarantee the accuracy or currency of any such information.

Related Capabilities